Cerebricon Ltd. Poster Sessions Society for Neuroscience
26 September 2005
CEREBRICON LTD: Announces Scientific Poster Presentations at this Years Society for Neuroscience Meeting in Washington DC, USA.
Cerebricon will be exhibiting at this years SFN at Booth 438. In addition to being represented at the exhibition Cerebricon Ltd. will be involved in 5 Scientific Posters:
Saturday, Nov 12th 1300 - 1400; Location MM24
Cognitive Decline, Histopathological and Biochemical Changes Induced by Infusion of Human ß-Amylloid in Rats
Monday, Nov. 14th 0800 - 0900; Location MM24
Unilateral Striatal 6-OHDA Infusion Model of Parkinson's Disease: Symptomatic and Neuroprotective Outcomes
Tuesday, Nov. 15th 1000 - 1100; Location SS96
A novel Minocycline Derivative, DM, Inhibits Activation of Inflammatory Cells and Ameliorates Neurobehavioral Deficits After Spinal Cord injury in Rats
Tuesday, Nov. 15th 1100 - 1200; Location SS4 7
Minocycline in a Rat Model of Stroke: Two Month Follow-Up Study
Wednesday, Nov 16th 1100 - 1200; Location SS66
The protective role of Novel Hybrid Antioxidant Molecules in In Vitro Ischemia and Oxidative Stress
